◆英語タイトル:Avanir Pharmaceuticals Inc - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2896
◆発行会社(調査会社):
GlobalData
◆発行日:2020年4月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Avanir Pharmaceuticals Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights
Avanir Pharmaceuticals Inc (Avanir), a subsidiary of Otsuka Pharmaceutical Co Ltd. is a biopharmaceutical company that focuses on the research, development and commercialization of medical and pharmaceutical treatments for central nervous system disorders. The company’s lead products include Nuedexta, a medication used for the treatment of pseudobulbar affect (PBA); and Onzetra Xsail, an intranasal medication delivery system used for the treatment of migraine. Its pipeline products are intended for the treatment of pseudobulbar affect, acute treatment of migraine, acute treatment of migraine in pediatrics, agitation in Alzheimer’s disease, residual schizophrenia, disinhibition in dementia and traumatic brain injury behavioral dysfunction, among others. Avanir is headquartered in Aliso Viejo, California, the US.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Avanir Pharmaceuticals Inc – Key Facts
Avanir Pharmaceuticals Inc – Key Employees
Avanir Pharmaceuticals Inc – Key Employee Biographies
Avanir Pharmaceuticals Inc – Major Products and Services
Avanir Pharmaceuticals Inc – History
Avanir Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Avanir Pharmaceuticals Inc – Business Description
Avanir Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Avanir Pharmaceuticals Inc – Strengths
Avanir Pharmaceuticals Inc – Weaknesses
Avanir Pharmaceuticals Inc – Opportunities
Avanir Pharmaceuticals Inc – Threats
Avanir Pharmaceuticals Inc – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Avanir Pharmaceuticals Inc, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Avanir Pharmaceuticals Inc, Key Facts
Avanir Pharmaceuticals Inc, Key Employees
Avanir Pharmaceuticals Inc, Key Employee Biographies
Avanir Pharmaceuticals Inc, Major Products and Services
Avanir Pharmaceuticals Inc, History
Avanir Pharmaceuticals Inc, Subsidiaries
Avanir Pharmaceuticals Inc, Key Competitors
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Avanir Pharmaceuticals Inc, Recent Deals Summary
List of Figures
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Avanir Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020